<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cardiovasc. Med.</abbrev-journal-title>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcvm.2023.1256792</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cardiovascular Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Serial RV wall stress measurements: association with right ventricular function in repaired Tetralogy of Fallot patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Minderhoud</surname><given-names>Savine C. S.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2543439/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Hirsch</surname><given-names>Alexander</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1376463/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Marin</surname><given-names>Francesca</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Kardys</surname><given-names>Isabella</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2080429/overview" />
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Rodr&#x00ED;guez-Matas</surname><given-names>Jos&#x00E9; F.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/561774/overview" />
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Chiastra</surname><given-names>Claudio</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/805649/overview" />
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Roos-Hesselink</surname><given-names>Jolien W.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Wentzel</surname><given-names>Jolanda J.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/266364/overview" />
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Helbing</surname><given-names>Willem A.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/411505/overview" />
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Akyildiz</surname><given-names>Ali C.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/687525/overview" />
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><addr-line>Department of Cardiology, Erasmus MC</addr-line>, <institution>University Medical Center Rotterdam</institution>, <addr-line>Rotterdam</addr-line>, <country>Netherlands</country></aff>
<aff id="aff2"><label><sup>2</sup></label><addr-line>Department of Radiology and Nuclear Medicine, Erasmus MC</addr-line>, <institution>University Medical Center Rotterdam</institution>, <addr-line>Rotterdam</addr-line>, <country>Netherlands</country></aff>
<aff id="aff3"><label><sup>3</sup></label><addr-line>Laboratory of Biological Structure Mechanics (LaBS), Department of Chemistry, Materials and Chemical Engineering &#x201C;Giulio Natta&#x201D;</addr-line>, <institution>Politecnico di Milano</institution>, <addr-line>Milan</addr-line>, <country>Italy</country></aff>
<aff id="aff4"><label><sup>4</sup></label><addr-line>PoliTo<sup>BIO</sup>Med Lab, Department of Mechanical and Aerospace Engineering</addr-line>, <institution>Politecnico di Torino</institution>, <addr-line>Turin</addr-line>, <country>Italy</country></aff>
<aff id="aff5"><label><sup>5</sup></label><addr-line>Division of Paediatric Cardiology, Department of Pediatrics, Erasmus MC</addr-line>, <institution>University Medical Center Rotterdam</institution>, <addr-line>Rotterdam</addr-line>, <country>Netherlands</country></aff>
<aff id="aff6"><label><sup>6</sup></label><addr-line>Division of Pediatric Cardiology, Department of Pediatrics</addr-line>, <institution>Radboud University Medical Center</institution>, <addr-line>Nijmegen</addr-line>, <country>Netherlands</country></aff>
<aff id="aff7"><label><sup>7</sup></label><addr-line>Department of Biomechanical Engineering</addr-line>, <institution>Delft University of Technology</institution>, <addr-line>Delft</addr-line>, <country>Netherlands</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Dalin Tang, Worcester Polytechnic Institute, United States</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Pim Oomen, University of California, Irvine, United States Han Yu, Queensland University of Technology, Australia</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Ali C. Akyildiz <email>a.akyildiz@erasmusmc.nl</email></corresp>
<fn fn-type="other" id="fn001"><p><bold>Abbreviations</bold> bSSFP, balanced steady-state free precession; CI, confidence interval; CMR, cardiovascular magnetic resonance; ECG, electrocardiography; EF, ejection fraction; FE, finite element; FOV, field-of-view; IQR, interquartile range; LV, left ventricular; NT-proBNP, <italic>N</italic>-terminal prohormone brain natriuretic peptide; PC, phase contrast; PR, pulmonary regurgitation; PVR, pulmonary valve replacement; RV, right ventricular; SD, standard deviation; TOF, Tetralogy of Fallot.</p></fn>
</author-notes>
<pub-date pub-type="epub"><day>19</day><month>10</month><year>2023</year></pub-date>
<pub-date pub-type="collection"><year>2023</year></pub-date>
<volume>10</volume><elocation-id>1256792</elocation-id>
<history>
<date date-type="received"><day>11</day><month>07</month><year>2023</year></date>
<date date-type="accepted"><day>29</day><month>09</month><year>2023</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2023 Minderhoud, Hirsch, Marin, Kardys, Rodr&#x00ED;guez-Matas, Chiastra, Roos-Hesselink, Wentzel, Helbing and Akyildiz.</copyright-statement>
<copyright-year>2023</copyright-year><copyright-holder>Minderhoud, Hirsch, Marin, Kardys, Rodr&#x00ED;guez-Matas, Chiastra, Roos-Hesselink, Wentzel, Helbing and Akyildiz</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec><title>Background</title>
<p>Optimal timing of pulmonary valve replacement (PVR) in Tetralogy of Fallot (TOF) patients remains challenging. Ventricular wall stress is considered to be an early marker of right ventricular (RV) dysfunction.</p>
</sec>
<sec><title>Objectives</title>
<p>To investigate the association of RV wall stresses and their change over time with functional parameters in TOF patients.</p>
</sec>
<sec><title>Methods</title>
<p>Ten TOF patients after surgical repair with moderate/severe pulmonary regurgitation were included. At two timepoints (median follow-up time 7.2 years), patient-specific computational biventricular models for wall stress assessment were created using CMR short-axis cine images and echocardiography-based RV pressures. RV ejection fraction (RVEF), NT-proBNP and cardiopulmonary exercise tests were used as outcome measures reflecting RV function. Associations between regional RV diastolic wall stress and RV function were investigated using linear mixed models.</p>
</sec>
<sec><title>Results</title>
<p>Increased wall stress correlated with lower RV mass (<italic>r</italic><sub>rm&#x2009;</sub>&#x003D;&#x2009;&#x2212;0.70, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.017) and lower RV mass-to-volume (<italic>r</italic><sub>rm&#x2009;</sub>&#x003D;&#x2009;&#x2212;0.80, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.003) using repeated measures. Wall stress decreased significantly over time, especially in patients with a stable RVEF (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001). Higher wall stress was independently associated with lower RVEF, adjusted for left ventricular ejection fraction, RV end-diastolic volume and time since initial surgery (decrease of 1.27&#x0025; RVEF per kPa increase in wall stress, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.029) using repeated measurements. No association was found between wall stress, NT-proBNP, and exercise capacity.</p>
</sec>
<sec><title>Conclusions</title>
<p>Using a computational method to calculate wall stress locally in geometrically complex ventricles, we demonstrated that lower wall stress might be important to maintain ventricular function. RV wall stress assessment can be used in serial follow-up, and is potentially an early marker of impending RV dysfunction.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Tetralogy of Fallot</kwd>
<kwd>right ventricle</kwd>
<kwd>cardiovascular magnetic resonance</kwd>
<kwd>computational modelling</kwd>
<kwd>wall stress</kwd>
</kwd-group>
<contract-num rid="cn001">&#x00A0;</contract-num>
<contract-sponsor id="cn001">Thorax Foundation and Stichting Hartekind</contract-sponsor>
<counts>
<fig-count count="5"/>
<table-count count="3"/><equation-count count="0"/><ref-count count="28"/><page-count count="0"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Clinical and Translational Cardiovascular Medicine</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro"><title>Introduction</title>
<p>Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect. Long-term survival of 72&#x0025; at 40 years after surgery has been reported (<xref ref-type="bibr" rid="B1">1</xref>). Heart failure and sudden cardiac death are the main causes of late mortality in these patients (<xref ref-type="bibr" rid="B1">1</xref>). Right ventricular (RV) function is an important parameter in this context as it is an independent predictor of mortality, sustained ventricular tachycardia and heart failure (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>Various factors contribute to RV dysfunction in TOF patients, including longstanding pulmonary regurgitation (PR) and/or stenosis (<xref ref-type="bibr" rid="B3">3</xref>). With the initial repair, pulmonary stenosis is relieved. However, many patients are left with PR. The resulting chronic volume overload leads to progressive RV dilatation and dysfunction (<xref ref-type="bibr" rid="B4">4</xref>). Pulmonary valve replacement (PVR) is often needed and may improve patient&#x0027;s condition. PVR should be timed before irreversible RV dysfunction occurs, but should also be timed late enough to limit the number of re-interventions (<xref ref-type="bibr" rid="B3">3</xref>). Current indicators for PVR timing may lead to suboptimal post-operative results. Better markers to predict impending RV functional decline are needed (<xref ref-type="bibr" rid="B5">5</xref>). Previously, end-diastolic mechanical stress in the RV wall was suggested as a predictor for post-operative RV ejection fraction (EF) response (<xref ref-type="bibr" rid="B6">6</xref>), indicating that this mechanical marker might be an early indicator of RV dysfunction.</p>
<p>RV wall stress in chronic PR, changes in wall stress over time and how this relates to clinical end points is currently unknown. Accordingly, this study aims to investigate the change in RV wall stress over time in TOF patients with moderate or severe PR, and to assess the association of wall stress with functional parameters.</p>
</sec>
<sec id="s2"><title>Material and methods</title>
<sec id="s2a"><title>Study population</title>
<p>Repaired TOF patients with the following criteria were enrolled: (1) &#x2265;moderate PR, (2) two sequential cardiovascular magnetic resonance (CMR) examinations with at least a time gap of four years in between and (3) echocardiography within one year from each CMR examination. Patients were selected from previous CMR studies (<xref ref-type="bibr" rid="B7">7</xref>&#x2013;<xref ref-type="bibr" rid="B9">9</xref>). Patients with a RV outflow tract intervention between the CMRs were excluded. Patients underwent a comprehensive clinical assessment, NT-proBNP measurements, cardiopulmonary exercise test, CMR examination and echocardiography, as previously reported (<xref ref-type="bibr" rid="B7">7</xref>). Percentage of predicted work load and percent predicted peak rate of oxygen consumption (VO<sub>2</sub>) were variables used from the results of cardiopulmonary exercise tests. Local institutional ethics committee approved the study, and all patients provided written informed consent.</p>
</sec>
<sec id="s2b"><title>CMR image acquisition and analysis</title>
<p>CMR images were acquired with clinical 1.5&#x2005;T MRI scanners (GE Healthcare, Milwaukee, Wisconsin, USA). Included patients had undergone a CMR examination with at least a stack short-axis balanced steady-state free precession (bSSFP) cine images and phase contrast (PC) imaging of the pulmonary artery. Using a retrospective ECG-gated bSSFP sequence during mild end-expiratory breath-hold, ten to fourteen contiguous short-axis images were acquired covering the left ventricle (LV) and RV from basis to apex. Typical scan parameters were field of view(FOV) 30&#x2013;38&#x2005;cm, phase FOV 75&#x0025;&#x2013;100&#x0025;, slice thickness of 6&#x2013;8&#x2005;mm with an interslice gap of 2&#x2013;4&#x2005;mm, matrix size 192&#x2009;&#x00D7;&#x2009;160 and 24 reconstructed phases per cardiac cycle (<xref ref-type="bibr" rid="B7">7</xref>). Breath-hold, retrospective ECG-gated through-plane PC imaging was planned perpendicular to the main pulmonary artery approximately 1&#x2005;cm distal of the valve and before the pulmonary artery bifurcation. VENC was set at 180&#x2005;cm/s and increased if necessary (<xref ref-type="bibr" rid="B7">7</xref>). Directly after the CMR examination, the exact same PC sequence parameters were used to scan a static gel phantom for phase off set error correction.</p>
<p>In Qmass (Medis, Leiden, The Netherlands), LV and RV endo- and epicardial contours were drawn on short axis CMR images during end-systole and end-diastole by one observer (SCSM) and were reviewed by a second observer (AH). Based on these contours, LV and RV end-diastolic volumes, end-systolic volumes and EF were calculated. RV mass was determined in end-systole &#x007B;[epicardial volume&#x2013;endocardial volume (in ml)]&#x2009;&#x00D7;&#x2009;1.05&#x2005;g/ml&#x007D;. Volumes and mass were corrected for body surface area. With QFlow (Medis, Leiden, The Netherlands), PR fraction and regurgitation volume were quantified using PC imaging. Flow measurements were obtained after background subtraction with a static gel phantom.</p>
</sec>
<sec id="s2c"><title>Echocardiography</title>
<p>RV diastolic pressure was derived based on the inferior vena cava diameter (&#x2264;20&#x2005;mm or &#x003E;20&#x2005;mm) and percentage of collapse (&#x2264;50&#x0025; or &#x003E;50) on echocardiography (<xref ref-type="bibr" rid="B10">10</xref>). The maximum peak gradient across the pulmonary valve was determined using Doppler measurements and calculated using the modified Bernoulli equation [&#x0394;P&#x2009;&#x003D;&#x2009;4&#x2009;&#x00D7;&#x2009;(V<sub>max</sub>)<sup>2</sup>].</p>
</sec>
<sec id="s2d"><title>Wall stress analysis</title>
<p>Diastolic wall stress and strain were calculated using finite element (FE) analysis performed with Abaqus/Standard (Dassault Syst&#x00E8;mes Simulia Corp., Providence, RI, USA). The stack of short axis CMR contours was interpolated to create three-dimensional biventricular models (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>). The LV and RV walls were assumed to be hyperelastic, incompressible and anisotropic (<xref ref-type="bibr" rid="B11">11</xref>) with material parameters taken from Wang et al. (<xref ref-type="bibr" rid="B12">12</xref>). A smooth transmural variation of the fibre orientation from &#x2212;70&#x00B0; at the epicardium to &#x002B;80&#x00B0; at the endocardium was assumed as described by Wong et al. and implemented in the computational models (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>CMR-based finite element cardiac modelling workflow. Three-dimensional geometric reconstruction was obtained through volumetric interpolation of stacked short axis contours. Fibre orientation, passive material properties and right ventricular diastolic pressure were implemented. With finite element analysis, ventricular wall stresses were calculated. Right ventricular free wall was divided in fifteen segments.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1256792-g001.tif"/>
</fig>
<p>Boundary and loading conditions were prescribed to the FE models as follows. Biventricular computational models were restrained from movement in the basal plane, simulating a stiff valvular plane. No constrains were applied to the apex that could move freely. Diastolic filling of the RV and LV was simulated by prescribing pressures on the ventricular endocardial surfaces. RV diastolic pressure estimate was obtained from echocardiography and assigned to the RV, while a physiological pressure of 9&#x2005;mmHg was assigned to the LV.</p>
<p>These three-dimensional, mechanical FE models were used to simulate the passive filling during diastole. In total, twenty FE models were generated for ten patients at two timepoints. The end-diastolic wall stress (maximum principal wall stress) and distributions of stress in the RV free wall were computed. Maximum principal stress is the maximum values of wall stress in any direction. Mesh independency of the FE results was confirmed by mesh convergence analysis.</p>
<p>For the analysis, the septal part of the RV wall was excluded, as the ventricular septum is considered to belong morphologically to the LV (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>). Because of regional variation of the magnitude of wall stress, a regional analysis approach was chosen. A standardized segmentation method for analysis of the LV was adapted and applied to the free wall of RV (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>) (<xref ref-type="bibr" rid="B14">14</xref>), using a previously proposed method to create fifteen segments of approximately equal size. First, the RV free wall was divided into apical, mid and basal regions, which were further subdivided into four, five and six segments respectively (<xref ref-type="bibr" rid="B15">15</xref>) (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>). These fifteen segments were also used to make a second division of the RV free wall into an anterior, lateral and posterior part (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>). The mean and 95th-percentile peak wall stresses were calculated per region. The weighted mean, defined as the mean of the fifteen regional values, and peak RV wall stresses per biventricular model were also calculated.</p>
</sec>
<sec id="s2e"><title>Statistical analysis</title>
<p>Continuous values were expressed as mean with standard deviation (SD) or, in case of skewed distribution, as median with a range or interquartile (IQR) range. Categorical data were summarized with frequencies and percentages. Regional wall stresses were log transformed because of a skewed distribution to calculate the geometric mean and geometric SD factor and are presented on the linear scale as geometric mean with range (geometric mean/geometric SD factor-geometric mean&#x2009;&#x00D7;&#x2009;geometric SD factor). Patients were divided in a group with a stable RVEF (RVEF follow-up minus RVEF baseline &#x2265;0&#x0025;) and a group with a decreasing RVEF (delta RVEF &#x003C;0&#x0025;) over time. RVEF was chosen because of its strong association with adverse clinical outcomes and exercise capacity in patients with repaired TOF (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). Continuous standard imaging parameters were compared with a Mann&#x2013;Whitney test between groups and with a Wilcoxon one-sample test between baseline and follow-up.</p>
<p>Linear mixed models with a random intercept for each patient were used to investigate (1) local differences in wall stress (average and 95th percentile wall stress) between RV free wall regions (basal vs. mid vs. apical) and parts (anterior vs. lateral vs. posterior) (2) local change in wall stress between baseline and follow-up (3) local wall stress differences between patients with a stable RVEF and with a decreasing RVEF (4) associations of wall stress with clinical end-points [RVEF, NT-proBNP, exercise testing (peak VO<sub>2</sub> and percentage of predicted work)] and (5) associations of baseline PR and PR volume with change of wall stress over time. To account for spatial autocorrelation between the wall stress regions, a spatial Gaussian correlation structure was used in the models 1&#x2013;3 and 5, based on the x-, y- and z-coordinates of regions. Standardized x-, y- and z-coordinates of regions were used for comparison between baseline and follow-up (model 2) and between patients (stable vs. decreasing RVEF, model 3) and. All models, except model 1, were corrected for time since initial surgery (follow-up duration), by adding this variable as a fixed effect.</p>
<p>All dependent parameters were transformed using log2 when the residuals plots showed deviation from normality. For visualization purposes, correlation plots were created showing the weighted mean wall stress values. For correlations between variables that include both baseline and follow-up measurements (repeated measurements), we controlled for within-individual association using a repeated measurement correlation (rmcorr package in R) (<xref ref-type="bibr" rid="B18">18</xref>). All analyses have been performed in R Statistical Software version 4.1.0 (R Foundation for Statistical Computing, Vienna, Austria). Two-tailed <italic>p</italic>-values below 0.05 were considered statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><title>Results</title>
<sec id="s3a"><title>Study population and clinical parameters</title>
<p>Ten patients were included in the study. Median age was 24 years (IQR 17&#x2013;28) at baseline and five (50&#x0025;) were males (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>). Median follow-up period between the baseline and follow-up CMR study was 7.2 years (IQR 6.9&#x2013;7.5). At baseline, median RV end-diastolic volume was 140&#x2005;ml/m<sup>2</sup> (IQR 129&#x2013;144), RVEF 46&#x0025; (IQR 42&#x2013;49), RV mass 15&#x2005;g/m<sup>2</sup> (IQR 12&#x2013;18), RV mass-to-volume ratio 0.11&#x2005;g/ml (IQR 0.09&#x2013;0.13) and PR 41&#x0025; (IQR 36&#x2013;45). All patients had &#x2264;mild tricuspid regurgitation during the both visits. Diastolic echocardiography-based RV pressures were estimated at 3&#x2005;mmHg (IQR 3&#x2013;3) in all patients at both timepoints. At follow-up, RV end-diastolic volume was 150&#x2005;ml/m<sup>2</sup> (IQR 144&#x2013;151) and RVEF was 46&#x0025; (IQR 44&#x2013;48) (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>). Overall, none of the parameters changed significantly between baseline and follow-up (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>). In four patients, RVEF decreased between baseline and follow-up. In these patients, RV mass decreased more and a larger PR volume per beat was present at baseline (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>).</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Baseline characteristics (<italic>n</italic>&#x2009;&#x003D;&#x2009;10).</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
</colgroup>
<tbody>
<tr>
<td valign="top" align="left">Male</td>
<td valign="top" align="center">5 (50&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Age (years)</td>
<td valign="top" align="center">24 (17&#x2013;28)</td>
</tr>
<tr>
<td valign="top" align="left">Height (cm)</td>
<td valign="top" align="center">172 (169&#x2013;175)</td>
</tr>
<tr>
<td valign="top" align="left">Weight (kg)</td>
<td valign="top" align="center">67 (61&#x2013;75)</td>
</tr>
<tr>
<td valign="top" align="left">BSA (m<sup>2</sup>)</td>
<td valign="top" align="center">1.78 (1.72&#x2013;1.87)</td>
</tr>
<tr>
<td valign="top" align="left">Systolic blood pressure (mmHg)</td>
<td valign="top" align="center">119 (102&#x2013;134)</td>
</tr>
<tr>
<td valign="top" align="left">Diastolic blood pressure (mmHg)</td>
<td valign="top" align="center">71 (63&#x2013;81)</td>
</tr>
<tr>
<td valign="top" align="left">NYHA class I</td>
<td valign="top" align="center">10 (100&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">QRS duration (ms)</td>
<td valign="top" align="center">97 (112&#x2013;143)</td>
</tr>
<tr>
<td valign="top" align="left">NT-proBNP (pmol/L)<xref ref-type="table-fn" rid="table-fn3"><sup>a</sup></xref></td>
<td valign="top" align="center">28 (12&#x2013;39)</td>
</tr>
<tr>
<td valign="top" align="left">Age of initial repair (years)</td>
<td valign="top" align="center">0.5 (0&#x2013;2.5)</td>
</tr>
<tr>
<td valign="top" align="left">Transannular patch, <italic>n</italic> (&#x0025;)</td>
<td valign="top" align="center">9 (90&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Follow-up period (years)<xref ref-type="table-fn" rid="table-fn4"><sup>b</sup></xref></td>
<td valign="top" align="center">7.2 (6.9&#x2013;7.5)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2">Cardiovascular magnetic resonance</td>
</tr>
<tr>
<td valign="top" align="left">LVEF (&#x0025;)</td>
<td valign="top" align="center">54 (50&#x2013;57)</td>
</tr>
<tr>
<td valign="top" align="left">RVESV indexed (ml/m<sup>2</sup>)</td>
<td valign="top" align="center">72 (75&#x2013;79)</td>
</tr>
<tr>
<td valign="top" align="left">RVEDV indexed (ml/m<sup>2</sup>)</td>
<td valign="top" align="center">140 (129&#x2013;144)</td>
</tr>
<tr>
<td valign="top" align="left">RVEF (&#x0025;)</td>
<td valign="top" align="center">46 (42&#x2013;49)</td>
</tr>
<tr>
<td valign="top" align="left">RV mass indexed (g/m<sup>2</sup>)</td>
<td valign="top" align="center">15 (12&#x2013;18)</td>
</tr>
<tr>
<td valign="top" align="left">RV mass-to-volume ratio (g/ml)</td>
<td valign="top" align="center">0.11 (0.09&#x2013;0.13)</td>
</tr>
<tr>
<td valign="top" align="left">PR fraction (&#x0025;)</td>
<td valign="top" align="center">41 (36&#x2013;45)</td>
</tr>
<tr>
<td valign="top" align="left">Pulmonary regurgitant volume (ml/beat)</td>
<td valign="top" align="center">48 (41&#x2013;60)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2">Echocardiography</td>
</tr>
<tr>
<td valign="top" align="left">Estimated RV diastolic pressure (mmHg)</td>
<td valign="top" align="center">3 (3&#x2013;3)</td>
</tr>
<tr>
<td valign="top" align="left">V<sub>max</sub> pulmonary valve (m/s)</td>
<td valign="top" align="center">2.0 (1.9&#x2013;2.1)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1"><p>Values are presented as median (IQR), number (percentage).</p></fn>
<fn id="table-fn2"><p>IQR, interquartile range; NYHA, New York heart association; NT-proBNP, N-terminal-pro brain B-type natriuretic peptide; LVEF, left ventricular ejection fraction; RVESV indexed, right ventricular end-systolic volume indexed to body surface area; RVEDV indexed, right ventricular end-diastolic volume indexed to body surface area; RV mass indexed, right ventricular mass indexed to body surface area; RVEF, right ventricular ejection fraction; RV, right ventricular; PR fraction, pulmonary regurgitation fraction.</p></fn>
<fn id="table-fn3"><label><sup>a</sup></label><p>Data of 8 patients.</p></fn>
<fn id="table-fn4"><label><sup>b</sup></label><p>Follow-up period between baseline and follow-up cardiovascular magnetic resonance.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Comparison of imaging parameters between patients with a stable and decreasing right ventricular ejection fraction.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">Total<break/>(<italic>n</italic>&#x2009;&#x003D;&#x2009;10)</th>
<th valign="top" align="center">Patients with a stable RVEF<break/>(<italic>n</italic>&#x2009;&#x003D;&#x2009;6)</th>
<th valign="top" align="center">Patients with a decreasing RVEF<break/>(<italic>n</italic>&#x2009;&#x003D;&#x2009;4)</th>
<th valign="top" align="center"><italic>p</italic>-value<xref ref-type="table-fn" rid="table-fn8">&#x002A;</xref></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="5">Baseline</td>
</tr>
<tr>
<td valign="top" align="left">RVEDV indexed (ml/m<sup>2</sup>)</td>
<td valign="top" align="center">140 (129&#x2013;144)</td>
<td valign="top" align="center">132 (120&#x2013;144)</td>
<td valign="top" align="center">147 (141&#x2013;165)</td>
<td valign="top" align="center">0.171</td>
</tr>
<tr>
<td valign="top" align="left">RV mass indexed (g/m<sup>2</sup>)</td>
<td valign="top" align="center">15 (12&#x2013;18)</td>
<td valign="top" align="center">13 (12&#x2013;16)</td>
<td valign="top" align="center">18 (16&#x2013;22)</td>
<td valign="top" align="center">0.067</td>
</tr>
<tr>
<td valign="top" align="left">RV mass-to-volume ratio (g/ml)</td>
<td valign="top" align="center">0.11 (0.09&#x2013;0.13)</td>
<td valign="top" align="center">0.10 (0.09&#x2013;0.11)</td>
<td valign="top" align="center">0.12 (0.10&#x2013;0.15)</td>
<td valign="top" align="center">0.610</td>
</tr>
<tr>
<td valign="top" align="left">PR fraction (&#x0025;)</td>
<td valign="top" align="center">41 (36&#x2013;45)</td>
<td valign="top" align="center">38 (27&#x2013;46)</td>
<td valign="top" align="center">41 (40&#x2013;45)</td>
<td valign="top" align="center">0.519</td>
</tr>
<tr>
<td valign="top" align="left">PR volume (ml/beat)<xref ref-type="table-fn" rid="table-fn7"><sup>a</sup></xref></td>
<td valign="top" align="center">48 (41&#x2013;60)</td>
<td valign="top" align="center">42 (32&#x2013;47)</td>
<td valign="top" align="center">60 (51&#x2013;76)</td>
<td valign="top" align="center">0.038</td>
</tr>
<tr>
<td valign="top" align="left">V<sub>max</sub> pulmonary valve (m/s)</td>
<td valign="top" align="center">2.0 (1.9&#x2013;2.1)</td>
<td valign="top" align="center">2.0 (1.7&#x2013;2.2)</td>
<td valign="top" align="center">2.0 (1.9&#x2013;2.0)</td>
<td valign="top" align="center">0.762</td>
</tr>
<tr>
<td valign="top" align="left" colspan="5">Follow-up</td>
</tr>
<tr>
<td valign="top" align="left">RVEDV indexed (ml/m<sup>2</sup>)</td>
<td valign="top" align="center">150 (144&#x2013;151)</td>
<td valign="top" align="center">144 (134&#x2013;151)</td>
<td valign="top" align="center">152 (150&#x2013;164)</td>
<td valign="top" align="center">0.114</td>
</tr>
<tr>
<td valign="top" align="left">RV mass indexed (g/m<sup>2</sup>)</td>
<td valign="top" align="center">17 (14&#x2013;18)</td>
<td valign="top" align="center">16 (14&#x2013;18)</td>
<td valign="top" align="center">16 (14&#x2013;18)</td>
<td valign="top" align="center">0.476</td>
</tr>
<tr>
<td valign="top" align="left">RV mass-to-volume ratio (g/ml)</td>
<td valign="top" align="center">0.12 (0.10&#x2013;0.13)</td>
<td valign="top" align="center">0.12 (0.12&#x2013;0.13)</td>
<td valign="top" align="center">0.12 (0.09&#x2013;0.13)</td>
<td valign="top" align="center">0.476</td>
</tr>
<tr>
<td valign="top" align="left">PR fraction (&#x0025;)</td>
<td valign="top" align="center">47 (34&#x2013;47)</td>
<td valign="top" align="center">43 (33&#x2013;47)</td>
<td valign="top" align="center">48 (47&#x2013;50)</td>
<td valign="top" align="center">0.067</td>
</tr>
<tr>
<td valign="top" align="left">PR volume (ml/beat)<xref ref-type="table-fn" rid="table-fn7"><sup>a</sup></xref></td>
<td valign="top" align="center">57 (36&#x2013;83)</td>
<td valign="top" align="center">50 (39&#x2013;71)</td>
<td valign="top" align="center">84 (83&#x2013;84)</td>
<td valign="top" align="center">0.010</td>
</tr>
<tr>
<td valign="top" align="left">V<sub>max</sub> pulmonary valve (m/s)</td>
<td valign="top" align="center">2.0 (1.7&#x2013;2.1)</td>
<td valign="top" align="center">2.0 (1.7&#x2013;2.1)</td>
<td valign="top" align="center">1.8 (1.7&#x2013;2.0)</td>
<td valign="top" align="center">0.668</td>
</tr>
<tr>
<td valign="top" align="left" colspan="5">Changes over time</td>
</tr>
<tr>
<td valign="top" align="left">&#x0394; RVEDV indexed (ml/m<sup>2</sup>)</td>
<td valign="top" align="center">6 (4&#x2013;8)</td>
<td valign="top" align="center">6 (6&#x2013;8)</td>
<td valign="top" align="center">4 (&#x2212;1&#x2013;8)</td>
<td valign="top" align="center">0.610</td>
</tr>
<tr>
<td valign="top" align="left">&#x0394; RV mass indexed (g/m<sup>2</sup>)</td>
<td valign="top" align="center">2 (0&#x2013;2)</td>
<td valign="top" align="center">2 (2&#x2013;5)</td>
<td valign="top" align="center">&#x2212;1 (&#x2212;2&#x2013;0)</td>
<td valign="top" align="center">0.010</td>
</tr>
<tr>
<td valign="top" align="left">&#x0394; RV mass-to-volume ratio (g/ml)</td>
<td valign="top" align="center">0.01 (&#x2212;0.01&#x2013;0.01)</td>
<td valign="top" align="center">0.01 (0.01&#x2013;0.02)</td>
<td valign="top" align="center">&#x2212;0.02 (&#x2212;0.02&#x2013;&#x2212;0.02)</td>
<td valign="top" align="center">0.067</td>
</tr>
<tr>
<td valign="top" align="left">&#x0394; PR fraction (&#x0025;)</td>
<td valign="top" align="center">3 (&#x2212;1&#x2013;5)</td>
<td valign="top" align="center">&#x2212;1 (&#x2212;4&#x2013;3)</td>
<td valign="top" align="center">6 (4&#x2013;7)</td>
<td valign="top" align="center">0.054</td>
</tr>
<tr>
<td valign="top" align="left">&#x0394; PR volume (ml/beat)<xref ref-type="table-fn" rid="table-fn7"><sup>a</sup></xref></td>
<td valign="top" align="center">1 (&#x2212;4&#x2013;13)</td>
<td valign="top" align="center">0 (&#x2212;4&#x2013;1)</td>
<td valign="top" align="center">23 (7&#x2013;32)</td>
<td valign="top" align="center">0.257</td>
</tr>
<tr>
<td valign="top" align="left">&#x0394; V<sub>max</sub> pulmonary valve (m/s)</td>
<td valign="top" align="center">0.1 (&#x2212;0.1&#x2013;0.3)</td>
<td valign="top" align="center">0.1 (0.1&#x2013;0.3)</td>
<td valign="top" align="center">&#x2212;0.2 (&#x2212;0.3&#x2013;0.1)</td>
<td valign="top" align="center">0.197</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5"><p>Median (IQR).</p></fn>
<fn id="table-fn6"><p>EDV, end-diastolic volume; IQR, interquartile range; RV, right ventricular; PR fraction, pulmonary regurgitation fraction; PR volume, pulmonary regurgitant volume; V<sub>max</sub>, peak velocity.</p></fn>
<fn id="table-fn7"><label><sup>a</sup></label><p>PR volume is the backward regurgitant volume per beat.</p></fn>
<fn id="table-fn8"><label>&#x002A;</label><p>Mann&#x2013;Whitney test.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3b"><title>Mechanical wall stress, ventricular volumes and mass</title>
<p><xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref> provides an overview of the regional wall stress distributions at baseline and follow-up per patient. Clear regional differences in wall stress patterns are observed within the RV, but also between baseline and follow-up and between patients. Weighted mean wall stress was 6.89&#x2005;kPa (IQR 5.29&#x2013;8.97) at baseline and 6.00&#x2005;kPa (IQR 5.56&#x2013;6.89) at follow-up and did not change significantly between baseline and follow-up (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.460). Correlations between average wall stress, RV volumes and mass measured both at baseline and at follow-up are presented in <xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>. Higher average wall stress was associated with lower RV mass (<italic>r</italic><sub>rm&#x2009;</sub>&#x003D;&#x2009;&#x2212;0.70, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.017, <xref ref-type="fig" rid="F3">Figure&#x00A0;3A</xref>) and lower mass-to-volume ratio (<italic>r</italic><sub>rm&#x2009;</sub>&#x003D;&#x2009;&#x2212;0.80, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.003, <xref ref-type="fig" rid="F3">Figure&#x00A0;3B</xref>). No associations were found between RV end-diastolic volume and mass and between RV end-diastolic volume and average wall stress (<xref ref-type="fig" rid="F3">Figures&#x00A0;3C</xref>,<xref ref-type="fig" rid="F3">D</xref>).</p>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>Overview of wall stress maps per patient. Top computational models refer to the baseline and bottom models refer to follow-up timepoint, stable RVEF indicates a stable RVEF over time and decrease RVEF indicates a decreasing RVEF over time. TOF, Tetralogy of Fallot.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1256792-g002.tif"/>
</fig>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>Correlations between wall stress, RV mass, volume and mass-to-volume ratio using repeated measurements. Repeated measures correlations for the relationship between (<bold>A</bold>) right ventricular mass indexed and weighted mean wall stress (<bold>B</bold>) right ventricular mass-to-volume ratio and weighted mean wall stress (<bold>C</bold>) right ventricular volume indexed and mass indexed (<bold>D</bold>) right ventricular end-diastolic volume indexed and average wall stress, measured two times in ten Tetralogy of Fallot patients. Longitudinal measurements and the correlation trend line are coloured per individual patient. <italic>r</italic><sub>rm</sub> is the correlation coefficient of within-individual association in repeated measures correlation, and the associated <italic>p</italic>-value is shown.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1256792-g003.tif"/>
</fig>
<p>Overall, at baseline, regional analysis showed that wall stress in the mid region (7.24&#x2009;&#x00B1;&#x2009;1.64&#x2005;kPa, mean, SD) was higher compared to wall stress in the basal region &#x007B;basal 5.40&#x2009;&#x00B1;&#x2009;1.70&#x2005;kPa, 0.37 difference [95&#x0025; confidence interval (CI) 0.11, 0.63], <italic>p</italic>&#x2009;&#x003D;&#x2009;0.006&#x007D; in log2 wall stress between mid and basal region), but not different from wall stress in the apical region [5.99&#x2009;&#x00B1;&#x2009;1.70&#x2005;kPa, 0.20 difference (95&#x0025; CI &#x2212;0.14, 0.53), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.248] in log2 wall stress between mid and apical region) (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>). Furthermore, wall stress in the lateral part was significantly higher than wall stress in the posterior part [0.42 difference (95&#x0025; CI 0.26, 0.58), <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001] in log2 wall stress between lateral and posterior part), which was in turn significantly higher than wall stress in the anterior part [0.96 difference (95&#x0025; CI 0.80, 1.12), <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001] in log2 wall stress between lateral and posterior part) (<xref ref-type="sec" rid="s12">Supplementary Table S1</xref>). The peak wall stress was also the highest in the mid region and lateral part (data not shown). Both at baseline and follow-up, no differences were observed in regional wall stress, RV end-diastolic volume, RV mass and RV mass-to-volume ratio between patients with a stable and decreasing RVEF (<xref ref-type="table" rid="T2">Tables&#x00A0;2</xref>, <xref ref-type="table" rid="T3">3</xref>).</p>
<table-wrap id="T3" position="float"><label>Table 3</label>
<caption><p>Regional wall stress changes over time stratified according to right ventricular function.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">Total<break/>(<italic>n</italic>&#x2009;&#x003D;&#x2009;10)</th>
<th valign="top" align="center">Patients with a stable RVEF<break/>(<italic>n</italic>&#x2009;&#x003D;&#x2009;6)</th>
<th valign="top" align="center">Patients with a decreasing RVEF<break/>(<italic>n</italic>&#x2009;&#x003D;&#x2009;4)</th>
<th valign="top" align="center">&#x03B2; (95&#x0025; CI)<xref ref-type="table-fn" rid="table-fn13">&#x002A;&#x002A;</xref></th>
<th valign="top" align="center"><italic>P</italic>-value<xref ref-type="table-fn" rid="table-fn13">&#x002A;&#x002A;</xref></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="6">Entire right ventricular free wall</td>
</tr>
<tr>
<td valign="top" align="left">Number of regions</td>
<td valign="top" align="center">150</td>
<td valign="top" align="center">90</td>
<td valign="top" align="center">60</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Wall stress baseline (kPa)</td>
<td valign="top" align="center">6.12 (3.61&#x2013;10.40)</td>
<td valign="top" align="center">6.91 (4.26&#x2013;11.22)</td>
<td valign="top" align="center">5.11 (2.96&#x2013;8.81)</td>
<td valign="top" align="center">0.43 (&#x2212;0.36, 1.22)<xref ref-type="table-fn" rid="table-fn11"><sup>a</sup></xref></td>
<td valign="top" align="center">0.246</td>
</tr>
<tr>
<td valign="top" align="left">Wall stress follow-up (kPa)</td>
<td valign="top" align="center">5.84 (3.54&#x2013;9.62)</td>
<td valign="top" align="center">5.58 (3.31&#x2013;9.40)</td>
<td valign="top" align="center">5.98 (3.57&#x2013;10.00)</td>
<td valign="top" align="center">0.04 (&#x2212;0.66, 0.75)<xref ref-type="table-fn" rid="table-fn11"><sup>a</sup></xref></td>
<td valign="top" align="center">0.889</td>
</tr>
<tr>
<td valign="top" align="left">Change over time (kPa)</td>
<td valign="top" align="center">&#x2212;0.41&#x2009;&#x00B1;&#x2009;3.42</td>
<td valign="top" align="center">&#x2212;1.39&#x2009;&#x00B1;&#x2009;3.94</td>
<td valign="top" align="center">1.06&#x2009;&#x00B1;&#x2009;1.55</td>
<td valign="top" align="center">&#x2212;2.79 (&#x2212;5.19, &#x2212;0.38)</td>
<td valign="top" align="center">0.029</td>
</tr>
<tr>
<td valign="top" align="left">&#x03B2; (95&#x0025; CI)<sup><xref ref-type="table-fn" rid="table-fn11">a</xref>,<xref ref-type="table-fn" rid="table-fn12">&#x002A;</xref></sup></td>
<td valign="top" align="center">&#x2212;0.54 (&#x2212;0.76, &#x2212;0.31)</td>
<td valign="top" align="center">&#x2212;0.53 (&#x2212;0.68, &#x2212;0.39)</td>
<td valign="top" align="center">&#x2212;0.20 (&#x2212;0.81, 0.42)</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="top" align="left"><italic>P</italic>-value baseline vs. FU<xref ref-type="table-fn" rid="table-fn12">&#x002A;</xref></td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.530</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="top" align="left" colspan="6">Basal right ventricular free wall</td>
</tr>
<tr>
<td valign="top" align="left">Number of regions</td>
<td valign="top" align="center">60</td>
<td valign="top" align="center">36</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Wall stress baseline (kPa)</td>
<td valign="top" align="center">5.40 (3.18&#x2013;9.17)</td>
<td valign="top" align="center">5.87 (3.63&#x2013;9.52)</td>
<td valign="top" align="center">4.77 (2.67&#x2013;8.52)</td>
<td valign="top" align="center">0.16 (&#x2212;0.64, 0.96)<xref ref-type="table-fn" rid="table-fn11"><sup>a</sup></xref></td>
<td valign="top" align="center">0.651</td>
</tr>
<tr>
<td valign="top" align="left">Wall stress follow-up (kPa)</td>
<td valign="top" align="center">5.34 (3.34&#x2013;8.56)</td>
<td valign="top" align="center">5.12 (3.13&#x2013;8.38)</td>
<td valign="top" align="center">5.70 (3.67&#x2013;8.83)</td>
<td valign="top" align="center">&#x2212;0.07 (&#x2212;0.76, 0.62)<xref ref-type="table-fn" rid="table-fn11"><sup>a</sup></xref></td>
<td valign="top" align="center">0.823</td>
</tr>
<tr>
<td valign="top" align="left">Change over time (kPa)</td>
<td valign="top" align="center">&#x2212;0.27&#x2009;&#x00B1;&#x2009;2.88</td>
<td valign="top" align="center">&#x2212;0.90&#x2009;&#x00B1;&#x2009;3.43</td>
<td valign="top" align="center">0.67&#x2009;&#x00B1;&#x2009;1.36</td>
<td valign="top" align="center">&#x2212;1.22 (&#x2212;3.33, 0.89)</td>
<td valign="top" align="center">0.294</td>
</tr>
<tr>
<td valign="top" align="left">&#x03B2; (95&#x0025; CI)<sup><xref ref-type="table-fn" rid="table-fn11">a</xref>,<xref ref-type="table-fn" rid="table-fn12">&#x002A;</xref></sup></td>
<td valign="top" align="center">&#x2212;0.20 (&#x2212;0.48, 0.08)</td>
<td valign="top" align="center">&#x2212;0.27 (&#x2212;0.59, 0.06)</td>
<td valign="top" align="center">&#x2212;0.12 (&#x2212;0.77, 0.53)</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="top" align="left"><italic>P</italic>-value baseline vs. FU<xref ref-type="table-fn" rid="table-fn12">&#x002A;</xref></td>
<td valign="top" align="center">0.167</td>
<td valign="top" align="center">0.111</td>
<td valign="top" align="center">0.718</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="top" align="left" colspan="6">Mid right ventricular free wall</td>
</tr>
<tr>
<td valign="top" align="left">Number of regions</td>
<td valign="top" align="center">50</td>
<td valign="top" align="center">30</td>
<td valign="top" align="center">20</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Wall stress baseline (kPa)</td>
<td valign="top" align="center">7.24 (4.43&#x2013;11.85)</td>
<td valign="top" align="center">8.38 (5.45&#x2013;12.88)</td>
<td valign="top" align="center">5.82 (3.50&#x2013;9.68)</td>
<td valign="top" align="center">0.55 (&#x2212;0.31, 1.42)<xref ref-type="table-fn" rid="table-fn11"><sup>a</sup></xref></td>
<td valign="top" align="center">0.174</td>
</tr>
<tr>
<td valign="top" align="left">Wall stress follow-up (kPa)</td>
<td valign="top" align="center">6.77 (4.35&#x2013;10.53)</td>
<td valign="top" align="center">6.16 (4.12&#x2013;9.21)</td>
<td valign="top" align="center">7.79 (4.85&#x2013;12.49)</td>
<td valign="top" align="center">&#x2212;0.24 (&#x2212;1.13, 0.65)<xref ref-type="table-fn" rid="table-fn11"><sup>a</sup></xref></td>
<td valign="top" align="center">0.546</td>
</tr>
<tr>
<td valign="top" align="left">Change over time (kPa)</td>
<td valign="top" align="center">&#x2212;0.65&#x2009;&#x00B1;&#x2009;3.22</td>
<td valign="top" align="center">&#x2212;2.49&#x2009;&#x00B1;&#x2009;2.71</td>
<td valign="top" align="center">2.11&#x2009;&#x00B1;&#x2009;1.46</td>
<td valign="top" align="center">&#x2212;4.87 (&#x2212;7.65, &#x2212;2.08)</td>
<td valign="top" align="center">0.004</td>
</tr>
<tr>
<td valign="top" align="left">&#x03B2; (95&#x0025; CI)<sup><xref ref-type="table-fn" rid="table-fn11">a</xref>,<xref ref-type="table-fn" rid="table-fn12">&#x002A;</xref></sup></td>
<td valign="top" align="center">&#x2212;0.40 (&#x2212;0.68, &#x2212;0.13)</td>
<td valign="top" align="center">&#x2212;0.66 (&#x2212;0.93, &#x2212;0.39)</td>
<td valign="top" align="center">0.06 (&#x2212;0.55, 0.67)</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="top" align="left"><italic>P</italic>-value baseline vs. FU<xref ref-type="table-fn" rid="table-fn12">&#x002A;</xref></td>
<td valign="top" align="center">0.004</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.848</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="top" align="left" colspan="6">Apical right ventricular free wall</td>
</tr>
<tr>
<td valign="top" align="left">Number of regions</td>
<td valign="top" align="center">40</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">16</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Wall stress baseline (kPa)</td>
<td valign="top" align="center">5.99 (3.52&#x2013;10.18)</td>
<td valign="top" align="center">6.92 (4.27&#x2013;11.21)</td>
<td valign="top" align="center">4.82 (2.81&#x2013;8.27)</td>
<td valign="top" align="center">0.56 (&#x2212;0.51&#x2013;1.64)<xref ref-type="table-fn" rid="table-fn11"><sup>a</sup></xref></td>
<td valign="top" align="center">0.257</td>
</tr>
<tr>
<td valign="top" align="left">Wall stress follow-up (kPa)</td>
<td valign="top" align="center">5.53 (3.11&#x2013;9.85)</td>
<td valign="top" align="center">5.60 (2.86&#x2013;11.01)</td>
<td valign="top" align="center">5.42 (3.61&#x2013;8.16)</td>
<td valign="top" align="center">&#x2212;0.11 (&#x2212;0.97, 0.74)<xref ref-type="table-fn" rid="table-fn11"><sup>a</sup></xref></td>
<td valign="top" align="center">0.801</td>
</tr>
<tr>
<td valign="top" align="left">Change over time (kPa)</td>
<td valign="top" align="center">&#x2212;0.33&#x2009;&#x00B1;&#x2009;4.36</td>
<td valign="top" align="center">&#x2212;0.77&#x2009;&#x00B1;&#x2009;5.53</td>
<td valign="top" align="center">0.33&#x2009;&#x00B1;&#x2009;1.30</td>
<td valign="top" align="center">&#x2212;2.55 (&#x2212;7.72, 2.61)</td>
<td valign="top" align="center">0.281</td>
</tr>
<tr>
<td valign="top" align="left">&#x03B2; (95&#x0025; CI)<sup><xref ref-type="table-fn" rid="table-fn11">a</xref>,<xref ref-type="table-fn" rid="table-fn12">&#x002A;</xref></sup></td>
<td valign="top" align="center">&#x2212;0.37 (&#x2212;0.67, &#x2212;0.07)</td>
<td valign="top" align="center">&#x2212;0.38 (&#x2212;0.68, &#x2212;0.08)</td>
<td valign="top" align="center">&#x2212;0.01 (&#x2212;0.86, 0.83)</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x2013;</td>
</tr>
<tr>
<td valign="top" align="left"><italic>P</italic>-value baseline vs. FU<xref ref-type="table-fn" rid="table-fn12">&#x002A;</xref></td>
<td valign="top" align="center">0.016</td>
<td valign="top" align="center">0.013</td>
<td valign="top" align="center">0.974</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x2013;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn9"><p>Values are presented as numbers, mean and standard deviation (SD) or in case of a skewed distribution as geometric mean and geometric SD factor presented on the linear scale as geometric mean with range (geometric mean/geometric SD factor&#x2014;geometric mean&#x2009;&#x00D7;&#x2009;geometric SD factor). Linear mixed effect models are created with wall stress as dependent variable and timepoint (baseline or follow-up) as independent variable adjusted for time since initial surgery. Models have a random intercept per patient and a spatial Gaussian correlation structure.</p></fn>
<fn id="table-fn10"><p>RVEF, right ventricular ejection fraction; FU, follow-up.</p></fn>
<fn id="table-fn11"><label><sup>a</sup></label><p>Results are presented as the mean difference with 95&#x0025; confidence interval (CI) of the wall stress expressed as 2log kPa.</p></fn>
<fn id="table-fn12"><label>&#x002A;</label><p>Comparing baseline with follow-up.</p></fn>
<fn id="table-fn13"><label>&#x002A;&#x002A;</label><p>Comparing patients with a stable and a declining RVEF.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3c"><title>Changes over time</title>
<p>Regional free wall stress of the RV decreased between baseline and follow-up [&#x2212;0.54 change (95&#x0025; CI &#x2212;0.76, &#x2212;0.31), <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, in log2 wall stress between baseline and follow-up]. While in patients with a decreasing RVEF, wall stress did not change significantly over time [&#x03B2; &#x2212;0.20 (95&#x0025; CI &#x2212;0.81, 0.42), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.530], in patients with a stable RVEF the wall stress decreased significantly [&#x03B2; &#x2212;0.53 (95&#x0025; CI &#x2212;0.68, &#x2212;0.39), <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001]. The regional free wall stress decrease over time in patients with a stable RVEF was larger compared to that of patients with a decreasing RVEF [&#x03B2; &#x2212;2.79 (95&#x0025; CI &#x2212;5.19, &#x2212;0.38), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.029] when corrected for follow-up period. The difference of the change of wall stress between the two groups was most prominent in the mid region [&#x03B2; &#x2212;4.87 (95&#x0025; CI &#x2212;7.65, &#x2212;2.08), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.004] and anterior part [&#x03B2; &#x2212;2.04 (95&#x0025; CI &#x2212;3.50, &#x2212;0.58), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.029]. Peak wall stress did not change over time, both in patients with a stable and with a decreasing RVEF.</p>
<p>Patients with a stable RVEF demonstrated a significant increase of RV mass and RV mass-to-volume ratio (both <italic>p</italic>&#x2009;&#x003D;&#x2009;0.031) between baseline and follow-up. These patients showed a larger RV mass increase during the follow-up period compared to patients with a decreasing RVEF (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.010). Addionally, there was a tendency towards a larger RV mass-to-volume ratio decrease in patients with a decreasing RVEF compared to patients with a stable RVEF (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.067) (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>). There were no significantly different changes in RV end-diastolic volume over time between patients with a decreasing RVEF and those with a stable RVEF.</p>
</sec>
<sec id="s3d"><title>Functional outcomes and wall stress</title>
<p>In <xref ref-type="fig" rid="F4">Figure&#x00A0;4A</xref>, the relationship between weighted mean wall stress of the free wall and RVEF is depicted. Higher wall stress was associated with a lower RVEF [&#x03B2; &#x2212;1.16&#x0025; RVEF per kPa increase in wall stress (95&#x0025; CI &#x2212;2.12, &#x2212;0.20), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.022]. When also corrected for LVEF, RV end-diastolic volume and time since surgery, average wall stress remained independently associated with RVEF [&#x03B2; &#x2212;1.27&#x0025; RVEF per kPa increase in wall stress (95&#x0025; CI &#x2212;2.36, &#x2212;0.18), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.029] (<xref ref-type="sec" rid="s12">Supplementary Table S2</xref>). Mass-to-volume ratio was not associated with RVEF (<xref ref-type="sec" rid="s12">Supplementary Table S2</xref>). There was also a tendency towards a negative association between weighted peak wall stresses and RVEF [&#x03B2; &#x2212;0.41&#x0025; RVEF per kPa increase in wall stress (95&#x0025; CI &#x2212;0.83, 0.01), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.055] (<xref ref-type="fig" rid="F4">Figure&#x00A0;4B</xref>).</p>
<fig id="F4" position="float"><label>Figure 4</label>
<caption><p>Association between RV ejection fraction and weighted mean wall stress using repeated measurements. Association between (<bold>A</bold>) weighted mean wall stress of the right ventricular (RV) free wall and RV ejection fraction (<bold>B</bold>) weighted peak wall stress of the RV free wall and RV ejection fraction, using repeated measurements at two timepoint in ten Tetralogy of Fallot patients. Longitudinal measurements and the correlation trend line are coloured per individual patient. <italic>r</italic><sub>rm</sub> is the correlation coefficient of within-individual association in repeated measures correlation, and the associated <italic>p</italic>-value is shown.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1256792-g004.tif"/>
</fig>
<p>Wall stress and peak wall stress at baseline were both not associated with the RVEF at follow-up (wall stress &#x03B2; &#x2212;0.15 (95&#x0025; CI &#x2212;1.49, 1.20), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.810, peak wall stress &#x03B2; 0.06 (95&#x0025; CI &#x2212;0.46, 0.58), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.805), corrected for follow-up duration. This was also the case when corrected for follow-up duration and RVEF at baseline.</p>
<p>At follow-up, the median NT-proBNP level was 22&#x2005;pmol/L (IQR 16&#x2013;43) and the median percentage of predicted work load was 92&#x0025; (IQR 88&#x2013;110). Wall stress at baseline was not associated with NT-proBNP and percentage of predicted work load at follow-up when corrected for follow-up period. Peak VO<sub>2</sub> was available at follow-up for only three patients. Therefore, analyses of this parameter as end-point were not performed.</p>
</sec>
<sec id="s3e"><title>Pulmonary regurgitation and wall stress</title>
<p>Finally, the relationship between PR and weighted mean wall stress was investigated (<xref ref-type="fig" rid="F5">Figure&#x00A0;5</xref>). Patients with a higher PR fraction and a larger pulmonary regurgitant volume at baseline exhibited a larger increase of wall stress between baseline and follow-up when corrected for follow-up duration (increase of wall stress of 0.14&#x2005;kPa per percentage increase in PR, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.024, and 0.07&#x2005;kPa increase of wall stress per ml PR volume increase, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.040). In addition, patients with a decreasing RVEF had a larger PR volume than patients with a stable RVEF both at baseline and follow-up (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>). There was no significant change of PR and/or PR volume over time in patients with a stable or decreasing RVEF.</p>
<fig id="F5" position="float"><label>Figure 5</label>
<caption><p>Association between pulmonary regurgitation and wall stress change over time. Association between (<bold>A</bold>) pulmonary regurgitation fraction (&#x0025;) at baseline and (<bold>B</bold>) pulmonary regurgitant volume (ml/beat) at baseline and change in wall stress over time. Beta coefficients and <italic>p</italic>-value are visualized from linear mixed models and can interpreted as follows increase of wall stress of 0.14&#x2005;kPa per percentage increase in pulmonary regurgitation fraction, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.024, and 0.07&#x2005;kPa increase of wall stress per ml pulmonary regurgitation volume increase, <italic>p</italic>&#x2009;&#x003D;&#x2009;0.040.</p></caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-10-1256792-g005.tif"/>
</fig>
<p>In accordance with the overall analysis, also baseline PR fraction was associated with regional changes in wall stress in the mid region &#x03B2; 0.21 (95&#x0025; CI 0.04, 0.38), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.025), anterior part &#x03B2; 0.11 (95&#x0025; CI 0.03, 0.19), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.015) and lateral part &#x03B2; 0.24 (95&#x0025; CI 0.10, 0.39), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.014) (<xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>). Also, PR volume at baseline was associated with regional wall stress changes in these regions (mid region &#x03B2; 0.11 (95&#x0025; CI 0.04, 0.19), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.010, anterior part &#x03B2; 0.05 (95&#x0025; CI 0.01, 0.10), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.033 and lateral part &#x03B2; 0.12 (95&#x0025; CI 0.04, 0.19), <italic>p</italic>&#x2009;&#x003D;&#x2009;0.021).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><title>Discussion</title>
<p>In this study, we investigated changes of mechanical wall stress in the RV wall over time with computational modelling using standard clinical CMR- and echocardiography parameters. We applied this technique in the TOF population. We were able to show the inverse relationship of ventricular wall stress in the RV free wall with RV mass, mass-to-volume ratio and function <italic>in-vivo</italic>. Furthermore, RV wall stress decreased significantly over time in patients with a stable RV function, whereas RV wall stress did not decrease in patients with a decreasing RV function. Finally, patients with more PR at baseline had greater increase of their RV free wall stress over time.</p>
<p>These findings suggest that the method we used to calculate wall stress might be a useful addition in clinical decision making in TOF. Furthermore, it provides insight in the pathophysiological mechanisms behind RV adaptation to severe pulmonary valve regurgitation, RV enlargement and RV dysfunction in TOF patients. The computational methodology we used allows to study the mechanical status of the ventricular wall, including the regional differences throughout the right ventricle. Input for the model is derived from standard CMR, which is already the golden standard imaging modality to monitor volume, function and PR in TOF patients, and is routinely collected during follow-up at regular intervals. The current computational model can be improved, so that the current time to construct (&#x00B1;8&#x2005;h) can be reduced until a clinically acceptable time.</p>
<p>Maintenance of adequate wall stress is a basic part of homeostasis in the ventricular wall. Previously, higher pre-operative ventricular wall stress has been associated with poorer PVR outcome in terms of RV function response to PVR in TOF patients (<xref ref-type="bibr" rid="B6">6</xref>). No studies are available on serial RV wall stress evaluation pre-PVR. In this study, in patients with at least moderate PR, ventricular wall stress decreased over time, particularly in patients that maintained their RVEF during follow-up, while in patients with deterioration of their RV function ventricular wall stress did not decrease. This suggests that wall stress might be a close marker of ventricular status than RVEF and RV volume assessment. Patients with a preserved RVEF increased their RV mass and RV mass-to-volume ratio. These are well-known mechanisms in ventricular adaptation to increased loading, aimed to normalized wall stress (<xref ref-type="bibr" rid="B19">19</xref>). To be able to recognize this process of wall stress adaptation in clinical practice, is, as stated, a potentially valuable tool.</p>
<p>In earlier studies, PR fraction and especially regurgitant volume has been associated with RV enlargement (<xref ref-type="bibr" rid="B20">20</xref>). Our findings suggest that the degree of PR has a direct effect on wall stress changes over time. Areas in which this relationship was most clear, were the mid and lateral part, which are located in the area of RV free wall most directly impacted by the pulmonary regurgitant flow jet. These regions correspond also to regions most prone to dilate (<xref ref-type="bibr" rid="B21">21</xref>). These studies and our findings suggest that PR might impact the ventricular wall locally and PR might be an important driver of wall stress increase.</p>
<p>Previous studies also indicate that PR is initially associated with more RV enlargement, mass-to-volume ratio decrease, thus resulting in higher wall stresses (<xref ref-type="bibr" rid="B22">22</xref>). However, this process is initially compensated by increasing the RV mass, keeping a relatively normal mass-to-volume ratio and preserving RV function (<xref ref-type="bibr" rid="B22">22</xref>). This was confirmed in the current study. Patients with a stable RVEF had less volume overload. In this group, there was an increase in mass and mass-to-volume ratio, while patients with a decreasing RVEF did not increase mass and mass-to-volume ratio. Consequently, these patients were not able to lower ventricular wall stress. The consequence of the lack of wall stress normalization is that myocardial perfusion could be impaired, resulting in a mismatch between blood flow supply and oxygen consumption. This could lead to decreased myocardial functioning, RV enlargement and ventricular wall thinning. RV mass-to-volume ratio was closely associated with wall stress, but was not associated RVEF changes over time.</p>
<p>Recently, attention has been drawn to RV geometric shape, which has been associated with exercise capacity, decrease in RV function and adverse events (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Wall stress is strongly depended on geometry. We hypothesize that these geometric adaptations might have led to unfavourable wall stress profile in the RV, thereby potentiates maladaptive remodelling and increases the risks on adverse events.</p>
<p>Strain, reflecting myocardial deformation, is a second mechanical parameter commonly measured. Previous studies suggest that a decrease of RV longitudinal strain and an increase RV circumferential strain in TOF patients compared to healthy controls (<xref ref-type="bibr" rid="B25">25</xref>). Both LV and RV strain have been associated with cardiovascular events (<xref ref-type="bibr" rid="B26">26</xref>). An unfavourable decrease of RV strain was observed in TOF patients over time (<xref ref-type="bibr" rid="B27">27</xref>). One study compared mechanical wall stress and strain, and this was around PVR. In that study, pre-operative wall stress was a better predictor of outcome after PVR than pre-operative strain (<xref ref-type="bibr" rid="B6">6</xref>). In this studies&#x0027; models, the passive filling is modelled meaning stress and strain are coupled directly mathematically, therefore, strain values were not reported separately.</p>
</sec>
<sec id="s5"><title>Study limitations</title>
<p>The present study has several limitations. In our computational model, no specific material properties were implemented for the patch area and scar tissue. Pressures were estimated with echocardiography as invasive pressures were not available. The study consists of a small group of patients and, therefore, the results on the differences between patients with a stable and decreasing RVEF should be interpreted with care. Active contraction was not implemented in our model, consequently we could not analyse the systole. Apical contouring was hard due to the partial volume effect. Therefore, wall stress in this region should be interpreted with caution. Furthermore, the RV wall is thin and hard to accurately delineate given the spatial resolution. To improve accuracy and consistency, all contours were checked by a second experienced observer. Results of RV wall mass and mass-to-volume ratio were comparable to those previously reported (<xref ref-type="bibr" rid="B28">28</xref>). Current methodology is time consuming (&#x00B1;8&#x2005;h) and analysis time should reduced for clinical implementation.</p>
</sec>
<sec id="s6" sec-type="conclusions"><title>Conclusion</title>
<p>Using computational modelling, RV mechanical wall stress was analysed in a regional manner in TOF patients. Wall stress was shown to closely relate to parameters such as RV mass, RV mass-to-volume ratio, PR and RVEF. This study demonstrates that RV wall stress can be determined based on routinely available input data and can be used in serial follow-up, providing a potential clinically relevant early marker of impending RV dysfunction.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="data-availability"><title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s8" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The studies involving humans were approved by The Medical Ethics Review Committee of the Erasmus Medical Center. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s9" sec-type="author-contributions"><title>Author contributions</title>
<p>SM: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Software, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. AH: Conceptualization, Funding acquisition, Methodology, Supervision, Validation, Writing &#x2013; review &#x0026; editing. FM: Data curation, Investigation, Software, Writing &#x2013; review &#x0026; editing. IK: Formal Analysis, Methodology, Writing &#x2013; review &#x0026; editing. JR-M: Conceptualization, Methodology, Software, Supervision, Writing &#x2013; review &#x0026; editing. CC: Conceptualization, Methodology, Software, Supervision, Writing &#x2013; review &#x0026; editing. JR-H: Funding acquisition, Supervision, Writing &#x2013; review &#x0026; editing. JW: Supervision, Writing &#x2013; review &#x0026; editing. WH: Conceptualization, Funding acquisition, Investigation, Methodology, Supervision, Validation, Visualization, Writing &#x2013; review &#x0026; editing. AA: Conceptualization, Funding acquisition, Methodology, Software, Supervision, Validation, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s10" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article.</p>
<p>This study was supported by the Thorax Foundation and Stichting Hartekind.</p>
</sec>
<sec id="s11" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s13" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material"><title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcvm.2023.1256792/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcvm.2023.1256792/full&#x0023;supplementary-material</ext-link></p>
<supplementary-material id="SD1" content-type="local-data">
<media mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="Table1.docx"/>
</supplementary-material>
<supplementary-material id="SD2" content-type="local-data">
<media mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="Table2.docx"/>
</supplementary-material>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cuypers</surname><given-names>JAAE</given-names></name><name><surname>Menting</surname><given-names>ME</given-names></name><name><surname>Konings</surname><given-names>EEM</given-names></name><name><surname>Opi&#x0107;</surname><given-names>P</given-names></name><name><surname>Utens</surname><given-names>EMWJ</given-names></name><name><surname>Helbing</surname><given-names>WA</given-names></name><etal/></person-group> <article-title>Unnatural history of tetralogy of Fallot: prospective follow-up of 40 years after surgical correction</article-title>. <source>Circulation</source>. (<year>2014</year>) <volume>130</volume>(<issue>22</issue>):<fpage>1944</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.114.009454</pub-id><pub-id pub-id-type="pmid">25341442</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knauth</surname><given-names>AL</given-names></name><name><surname>Gauvreau</surname><given-names>K</given-names></name><name><surname>Powell</surname><given-names>AJ</given-names></name><name><surname>Landzberg</surname><given-names>MJ</given-names></name><name><surname>Walsh</surname><given-names>EP</given-names></name><name><surname>Lock</surname><given-names>JE</given-names></name><etal/></person-group> <article-title>Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair</article-title>. <source>Heart</source>. (<year>2008</year>) <volume>94</volume>(<issue>2</issue>):<fpage>211</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/hrt.2006.104745</pub-id><pub-id pub-id-type="pmid">17135219</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van der Ven</surname><given-names>JPG</given-names></name><name><surname>van den Bosch</surname><given-names>E</given-names></name><name><surname>Bogers</surname><given-names>AJCC</given-names></name><name><surname>Helbing</surname><given-names>WA</given-names></name></person-group>. <article-title>Current outcomes and treatment of tetralogy of Fallot</article-title>. <source>F1000Res</source>. (<year>2019</year>) <volume>8</volume>:<fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.12688/f1000research.17174.1</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wald</surname><given-names>RM</given-names></name><name><surname>Valente</surname><given-names>AM</given-names></name><name><surname>Gauvreau</surname><given-names>K</given-names></name><name><surname>Babu-Narayan</surname><given-names>SV</given-names></name><name><surname>Assenza</surname><given-names>GE</given-names></name><name><surname>Schreier</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Cardiac magnetic resonance markers of progressive RV dilation and dysfunction after tetralogy of Fallot repair</article-title>. <source>Heart</source>. (<year>2015</year>) <volume>101</volume>(<issue>21</issue>):<fpage>1724</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2015-308014</pub-id><pub-id pub-id-type="pmid">26276804</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrild</surname><given-names>DM</given-names></name><name><surname>Berul</surname><given-names>CI</given-names></name><name><surname>Cecchin</surname><given-names>F</given-names></name><name><surname>Geva</surname><given-names>T</given-names></name><name><surname>Gauvreau</surname><given-names>K</given-names></name><name><surname>Pigula</surname><given-names>F</given-names></name><etal/></person-group> <article-title>Pulmonary valve replacement in tetralogy of Fallot. Impact on survival and ventricular tachycardia</article-title>. <source>Circulation</source>. (<year>2009</year>) <volume>119</volume>(<issue>3</issue>):<fpage>445</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.775221</pub-id><pub-id pub-id-type="pmid">19139389</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>del Nido</surname><given-names>PJ</given-names></name><name><surname>Zuo</surname><given-names>H</given-names></name><name><surname>Rathod</surname><given-names>RH</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><etal/></person-group> <article-title>Mechanical stress is associated with right ventricular response to pulmonary valve replacement in patients with repaired tetralogy of Fallot</article-title>. <source>J Thorac Cardiovasc Surg</source>. (<year>2016</year>) <volume>151</volume>(<issue>3</issue>):<fpage>687</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtcvs.2015.09.106</pub-id><pub-id pub-id-type="pmid">26548998</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luijnenburg</surname><given-names>SE</given-names></name><name><surname>Mekic</surname><given-names>S</given-names></name><name><surname>van den Berg</surname><given-names>J</given-names></name><name><surname>van der Geest</surname><given-names>RJ</given-names></name><name><surname>Moelker</surname><given-names>A</given-names></name><name><surname>Roos-Hesselink</surname><given-names>JW</given-names></name><etal/></person-group> <article-title>Ventricular response to dobutamine stress relates to the change in peak oxygen uptake during the 5-year follow-up in young patients with repaired tetralogy of Fallot</article-title>. <source>Eur Heart J Cardiovasc Imaging</source>. (<year>2014</year>) <volume>15</volume>(<issue>2</issue>):<fpage>189</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1093/ehjci/jet130</pub-id><pub-id pub-id-type="pmid">23867136</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duppen</surname><given-names>N</given-names></name><name><surname>Geerdink</surname><given-names>LM</given-names></name><name><surname>Kuipers</surname><given-names>IM</given-names></name><name><surname>Bossers</surname><given-names>SSM</given-names></name><name><surname>Koopman</surname><given-names>LP</given-names></name><name><surname>van Dijk</surname><given-names>APJ</given-names></name><etal/></person-group> <article-title>Regional ventricular performance and exercise training in children and young adults after repair of tetralogy of Fallot: randomized controlled pilot study</article-title>. <source>Circ Cardiovasc Imaging</source>. (<year>2015</year>) <volume>8</volume>(<issue>4</issue>):<fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCIMAGING.114.002006</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van den Bosch</surname><given-names>E</given-names></name><name><surname>van Genuchten</surname><given-names>WJ</given-names></name><name><surname>Luijnenburg</surname><given-names>SE</given-names></name><name><surname>Duppen</surname><given-names>N</given-names></name><name><surname>Kamphuis</surname><given-names>VP</given-names></name><name><surname>Roos-Hesselink</surname><given-names>JW</given-names></name><etal/></person-group> <article-title>Associations between blood biomarkers, cardiac function and adverse outcome in a young tetralogy of Fallot cohort</article-title>. <source>Int J Cardiol</source>. (<year>2022</year>) <volume>361</volume>:<fpage>31</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2022.04.065</pub-id><pub-id pub-id-type="pmid">35487320</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>RM</given-names></name><name><surname>Badano</surname><given-names>LP</given-names></name><name><surname>Victor</surname><given-names>MA</given-names></name><name><surname>Afilalo</surname><given-names>J</given-names></name><name><surname>Armstrong</surname><given-names>A</given-names></name><name><surname>Ernande</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging</article-title>. <source>J Am Soc Echocardiogr</source>. (<year>2015</year>) <volume>28</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.echo.2014.10.003</pub-id><pub-id pub-id-type="pmid">25559473</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holzapfel</surname><given-names>GA</given-names></name><name><surname>Ogden</surname><given-names>RW</given-names></name></person-group>. <article-title>Constitutive modelling of passive myocardium: a structurally based framework for material characterization</article-title>. <source>Phil Trans R Soc A</source>. (<year>2009</year>) <volume>367</volume>(<issue>1902</issue>):<fpage>3445</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1098/rsta.2009.0091</pub-id><pub-id pub-id-type="pmid">19657007</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HM</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>XY</given-names></name><name><surname>Berry</surname><given-names>C</given-names></name><name><surname>Griffith</surname><given-names>BE</given-names></name><name><surname>Ogden</surname><given-names>RW</given-names></name><etal/></person-group> <article-title>Structure-based finite strain modelling of the human left ventricle in diastole</article-title>. <source>Int J Numer Method Biomed Eng</source>. (<year>2013</year>) <volume>29</volume>(<issue>1</issue>):<fpage>83</fpage>&#x2013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1002/cnm.2497</pub-id><pub-id pub-id-type="pmid">23293070</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Kuhl</surname><given-names>E</given-names></name></person-group>. <article-title>Generating fiber orientation maps in human heart models using poisson interpolation</article-title>. <source>Comput Methods Biomech Biomed Engin</source>. (<year>2014</year>) <volume>17</volume>(<issue>11</issue>):<fpage>1217</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1080/10255842.2012.739167</pub-id><pub-id pub-id-type="pmid">23210529</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cerqueira</surname><given-names>MD</given-names></name><name><surname>Weissman</surname><given-names>NJ</given-names></name><name><surname>Dilsizian</surname><given-names>V</given-names></name><name><surname>Jacobs</surname><given-names>AK</given-names></name><name><surname>Kaul</surname><given-names>S</given-names></name><name><surname>Laskey</surname><given-names>WK</given-names></name><etal/></person-group> <article-title>Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart</article-title>. <source>Circulation</source>. (<year>2002</year>) <volume>105</volume>(<issue>4</issue>):<fpage>539</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1161/hc0402.102975</pub-id><pub-id pub-id-type="pmid">11815441</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wald</surname><given-names>RM</given-names></name><name><surname>Haber</surname><given-names>I</given-names></name><name><surname>Wald</surname><given-names>R</given-names></name><name><surname>Valente</surname><given-names>AM</given-names></name><name><surname>Powell</surname><given-names>AJ</given-names></name><name><surname>Geva</surname><given-names>T</given-names></name></person-group>. <article-title>Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot</article-title>. <source>Circulation</source>. (<year>2009</year>) <volume>119</volume>(<issue>10</issue>):<fpage>1370</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.816546</pub-id><pub-id pub-id-type="pmid">19255342</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valente</surname><given-names>AM</given-names></name><name><surname>Gauvreau</surname><given-names>K</given-names></name><name><surname>Assenza</surname><given-names>GE</given-names></name><name><surname>Babu-Narayan</surname><given-names>SV</given-names></name><name><surname>Schreier</surname><given-names>J</given-names></name><name><surname>Gatzoulis</surname><given-names>MA</given-names></name><etal/></person-group> <article-title>Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort</article-title>. <source>Heart</source>. (<year>2014</year>) <volume>100</volume>(<issue>3</issue>):<fpage>247</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2013-304958</pub-id><pub-id pub-id-type="pmid">24179163</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rashid</surname><given-names>I</given-names></name><name><surname>Mahmood</surname><given-names>A</given-names></name><name><surname>Ismail</surname><given-names>TF</given-names></name><name><surname>O&#x2019;Meagher</surname><given-names>S</given-names></name><name><surname>Kutty</surname><given-names>S</given-names></name><name><surname>Celermajer</surname><given-names>D</given-names></name><etal/></person-group> <article-title>Right ventricular systolic dysfunction but not dilatation correlates with prognostically significant reductions in exercise capacity in repaired tetralogy of Fallot</article-title>. <source>Eur Heart J Cardiovasc Imaging</source>. (<year>2020</year>) <volume>21</volume>(<issue>8</issue>):<fpage>906</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1093/ehjci/jez245</pub-id><pub-id pub-id-type="pmid">31578553</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bakdash</surname><given-names>JZ</given-names></name><name><surname>Marusich</surname><given-names>LR</given-names></name></person-group>. <article-title>Repeated measures correlation</article-title>. <source>Front Psychol</source>. (<year>2017</year>) <volume>8</volume>(<issue>456</issue>):<fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.3389/fpsyg.2017.00456</pub-id><pub-id pub-id-type="pmid">28197108</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grossman</surname><given-names>W</given-names></name><name><surname>Jones</surname><given-names>D</given-names></name><name><surname>McLaurin</surname><given-names>LP</given-names></name></person-group>. <article-title>Wall stress and patterns of hypertrophy in the human left ventricle</article-title>. <source>J Clin Invest</source>. (<year>1975</year>) <volume>56</volume>(<issue>1</issue>):<fpage>56</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1172/JCI108079</pub-id><pub-id pub-id-type="pmid">124746</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wald</surname><given-names>RM</given-names></name><name><surname>Redington</surname><given-names>AN</given-names></name><name><surname>Pereira</surname><given-names>A</given-names></name><name><surname>Provost</surname><given-names>YL</given-names></name><name><surname>Paul</surname><given-names>NS</given-names></name><name><surname>Oechslin</surname><given-names>EN</given-names></name><etal/></person-group> <article-title>Refining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume?</article-title> <source>Eur Heart J</source>. (<year>2009</year>) <volume>30</volume>(<issue>3</issue>):<fpage>356</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehn595</pub-id><pub-id pub-id-type="pmid">19164336</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bodhey</surname><given-names>NK</given-names></name><name><surname>Beerbaum</surname><given-names>P</given-names></name><name><surname>Sarikouch</surname><given-names>S</given-names></name><name><surname>Kropf</surname><given-names>S</given-names></name><name><surname>Lange</surname><given-names>P</given-names></name><name><surname>Berger</surname><given-names>F</given-names></name><etal/></person-group> <article-title>Functional analysis of the components of the right ventricle in the setting of tetralogy of Fallot</article-title>. <source>Circ Cardiovasc Imaging</source>. (<year>2008</year>) <volume>1</volume>(<issue>2</issue>):<fpage>141</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCIMAGING.108.783795</pub-id><pub-id pub-id-type="pmid">19808531</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geva</surname><given-names>T</given-names></name></person-group>. <article-title>Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support</article-title>. <source>J Cardiovasc Magn Reson</source>. (<year>2011</year>) <volume>13</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1186/1532-429X-13-9</pub-id><pub-id pub-id-type="pmid">21208447</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>M&#x00EE;ra</surname><given-names>A</given-names></name><name><surname>Lamata</surname><given-names>P</given-names></name><name><surname>Pushparajah</surname><given-names>K</given-names></name><name><surname>Abraham</surname><given-names>G</given-names></name><name><surname>Mauger</surname><given-names>CA</given-names></name><name><surname>McCulloch</surname><given-names>AD</given-names></name><etal/></person-group> <article-title>Le c&#x0153;ur en sabot: shape associations with adverse events in repaired tetralogy of Fallot</article-title>. <source>J Cardiovasc Magn Reson</source>. (<year>2022</year>) <volume>24</volume>(<issue>1</issue>):<fpage>46</fpage>. <pub-id pub-id-type="doi">10.1186/s12968-022-00877-x</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kollar</surname><given-names>S</given-names></name><name><surname>Balaras</surname><given-names>E</given-names></name><name><surname>Olivieri</surname><given-names>LJ</given-names></name><name><surname>Loke</surname><given-names>YH</given-names></name><name><surname>Capuano</surname><given-names>F</given-names></name></person-group>. <article-title>Statistical shape modeling reveals the link between right ventricular shape, hemodynamic force, and myocardial function in patients with repaired tetralogy of Fallot</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. (<year>2022</year>) <volume>323</volume>(<issue>3</issue>):<fpage>H449</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00228.2022</pub-id><pub-id pub-id-type="pmid">35839154</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kempny</surname><given-names>A</given-names></name><name><surname>Fern&#x00E1;ndez-Jim&#x00E9;nez</surname><given-names>R</given-names></name><name><surname>Orwat</surname><given-names>S</given-names></name><name><surname>Schuler</surname><given-names>P</given-names></name><name><surname>Bunck</surname><given-names>AC</given-names></name><name><surname>Maintz</surname><given-names>D</given-names></name><etal/></person-group> <article-title>Quantification of biventricular myocardial function using cardiac magnetic resonance feature tracking, endocardial border delineation and echocardiographic speckle tracking in patients with repaired tetralogy of Fallot and healthy controls</article-title>. <source>J Cardiovasc Magn Reson</source>. (<year>2012</year>) <volume>14</volume>(<issue>32</issue>):<fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1186/1532-429X-14-32</pub-id><pub-id pub-id-type="pmid">22226320</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orwat</surname><given-names>S</given-names></name><name><surname>Diller</surname><given-names>GP</given-names></name><name><surname>Kempny</surname><given-names>A</given-names></name><name><surname>Radke</surname><given-names>R</given-names></name><name><surname>Peters</surname><given-names>B</given-names></name><name><surname>K&#x00FC;hne</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Myocardial deformation parameters predict outcome in patients with repaired tetralogy of Fallot</article-title>. <source>Heart</source>. (<year>2016</year>) <volume>102</volume>(<issue>3</issue>):<fpage>209</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2015-308569</pub-id><pub-id pub-id-type="pmid">26715570</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monti</surname><given-names>CB</given-names></name><name><surname>Secchi</surname><given-names>F</given-names></name><name><surname>Capra</surname><given-names>D</given-names></name><name><surname>Guarnieri</surname><given-names>G</given-names></name><name><surname>Lastella</surname><given-names>G</given-names></name><name><surname>Barbaro</surname><given-names>U</given-names></name><etal/></person-group> <article-title>Right ventricular strain in repaired tetralogy of Fallot with regards to pulmonary valve replacement</article-title>. <source>Eur J Radiol</source>. (<year>2020</year>) <volume>131</volume>:<fpage>1</fpage>&#x2013;<lpage>6</lpage>.</citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luijnenburg</surname><given-names>SE</given-names></name><name><surname>Helbing</surname><given-names>WA</given-names></name><name><surname>Moelker</surname><given-names>A</given-names></name><name><surname>Kroft</surname><given-names>LJM</given-names></name><name><surname>Groenink</surname><given-names>M</given-names></name><name><surname>Roos-Hesselink</surname><given-names>JW</given-names></name><etal/></person-group> <article-title>5-year Serial follow-up of clinical condition and ventricular function in patients after repair of tetralogy of Fallot</article-title>. <source>Int J Cardiol</source>. (<year>2013</year>) <volume>169</volume>(<issue>6</issue>):<fpage>439</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2013.10.013</pub-id><pub-id pub-id-type="pmid">24182670</pub-id></citation></ref></ref-list>
</back>
</article>